Menopause-related brain fog is a collection of temporary cognitive changes that many women experience during perimenopause and menopause While scrolling on social media, you may have come across content claiming that testosterone is the ultimate fix for menopause-related brain fog.
Orthodontic tooth movement relies on mechanical force to remodel alveolar bone, yet how periodontal ligament (PDL) fibroblasts convert mechanical cues into signals that favor bone formation remains unclear. A new study shows that tensile force activates glycolysis in PDL fibroblasts,…
The results of the trial indicated that the jumping program not only helped maintain bone health but also reversed expected age-related bone loss in areas most vulnerable to fractures. These include the hip bone; the lumbar spine, or vertebral bones…
Social media has been rife with claims testosterone helps with menopause, but a new study finds insufficient evidence Testosterone has shown “insufficient” evidence to support social media claims that it can improve certain symptoms linked to the menopause, according to…
Testosterone enhancers are commonly used supplements that increase natural testosterone production in males. These supplements can aid in muscle development, enhance endurance and vitality, raise sex drive, and improve overall well-being. Much like the soil essential for nurturing a money…
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes. Night sweats are a common manifestation of menopause, but rapid symptom onset, drenching episodes, and accompanying systemic symptoms may indicate…
TMS 2026: OB/GYN visits had nearly 4-fold higher odds of menopause coding than family medicine visits, with disparities by race and insurance, a study found. Menopause-related diagnoses were documented in fewer than 8% of outpatient encounters among midlife women, with significant…
Investigational CagriSema produced 23.1% to 26.7% weight loss across menopause stages at 68 weeks, with improvements in cardiometabolic risk factors. Investigational CagriSema was associated with mean weight reductions ranging from 23.1% to 26.7% across menopause stages at 68 weeks, with additional improvements in waist circumference and…
TMS 2026: Only 21.7% of women initiated menopause hormone therapy, with significant racial disparities and low treatment persistence, a new study finds. Only 21.7% of more than 318 000 women initiated systemic hormone therapy (HT) within 12 months of a natural menopause diagnosis, and fewer than…
TMS 2026: Nearly 67% of US women receiving elinzanetant achieved at least a 50% reduction in menopausal VMS frequency by week 12 in pooled phase 3 trial data. Among 410 US participants, 66.9% of women receiving elinzanetant 120 mg daily achieved at least a 50% reduction in VMS frequency…
Perimenopause care, HRT, symptom management, and long‑term bone/heart health.
An article joins this feed when it matches these terms. Each one is also a search of its own.